Recent advances in the discovery and development of anti-influenza drugs
- 1 June 2002
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 12 (6) , 845-861
- https://doi.org/10.1517/13543776.12.6.845
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999
- New Approaches to Influenza ChemotherapyDrugs, 1998
- C3-Thia and C3-carba isosteres of a carbocyclic influenza neuraminidase inhibitor, (3R,4R,5S)-4-acetamido-5-amino-3-propoxyl-1-cyclohexene-1-carboxylic acidBioorganic & Medicinal Chemistry Letters, 1997
- Synthesis and activity of C2-substituted analogs of influenza neuraminidase inhibitor GS 4071Bioorganic & Medicinal Chemistry Letters, 1997
- Taking aim at a moving target — inhibitors of influenza virus Part 2: viral replication, packaging and releaseDrug Discovery Today, 1996
- Taking aim at a moving target-inhibitors of influenza virus Part 1 : virus adsorption, entry and uncoatingDrug Discovery Today, 1996
- Novel inhibitors of influenza sialidase related to GG167 Synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza a virus sialidaseBioorganic & Medicinal Chemistry Letters, 1996
- Evidence for a sialosyl cation transition‐state complex in the reaction of sialidase from influenza virusEuropean Journal of Biochemistry, 1992
- Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in FamiliesNew England Journal of Medicine, 1989